Detalhe da pesquisa
1.
Independent Blinded Validation of a Tissue Systems Pathology Test to Predict Progression in Patients With Barrett's Esophagus.
Am J Gastroenterol
; 115(6): 843-852, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079863
2.
Use of p53 immunohistochemistry in conjunction with routine histology improves risk stratification of patients with Barrett's oesophagus during routine clinical care.
Histopathology
; 77(3): 481-491, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32431062
3.
Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.
Gastroenterology
; 155(1): 156-167, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29608884
4.
Low-grade dysplasia diagnosis ratio and progression metrics identify variable Barrett's esophagus risk stratification proficiency in independent pathology practices.
Gastrointest Endosc
; 88(5): 807-815.e2, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29944863
5.
Tumor cell p38 inhibition to overcome immunotherapy resistance.
Res Sq
; 2023 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645831
6.
Parallel Evolution of Tobramycin Resistance across Species and Environments.
mBio
; 11(3)2020 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32457248
7.
Experimental Evolution In Vivo To Identify Selective Pressures during Pneumococcal Colonization.
mSystems
; 5(3)2020 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32398278